| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/10/2023 | Onconova Therapeutics, Inc. | ONTX | Grant | Stock Option (right to purchase) | 66.5k | $1.02 | $67.8k | | 08/10/2023 |
| 08/18/2022 | Onconova Therapeutics, Inc. | ONTX | Grant | Stock Option (right to purchase) | 66.5k | $1.26 | $83.7k | | 08/18/2022 |
| 06/16/2022 | Celldex Therapeutics, Inc. | CLDX | Grant | | 13.6k | $22.48 | $305.7k | | 06/16/2022 |
| 09/28/2021 | Onconova Therapeutics, Inc. | ONTX | Purchase | Common Stock | 6k | $4.20 | $25k | | 09/28/2021 |
| 07/30/2021 | Onconova Therapeutics, Inc. | ONTX | Grant | Stock Option (right to purchase) | 13k | $4.97 | $64.6k | | 07/30/2021 |
| 06/17/2021 | Celldex Therapeutics, Inc. | CLDX | Grant | | 12k | $28.00 | $336k | | 06/17/2021 |
| 02/16/2021 | Onconova Therapeutics, Inc. | ONTX | Purchase | Common Stock | 25k | $1.00 | $25k | | 02/16/2021 |
| 11/24/2020 | Onconova Therapeutics, Inc. | ONTX | Purchase | Common Stock | 38.8k | $0.26 | $10k | | 11/24/2020 |
| 06/18/2020 | Celldex Therapeutics, Inc. | CLDX | Grant | | 11k | $10.38 | $114.2k | | 06/18/2020 |
| 06/09/2020 | Celldex Therapeutics, Inc. | CLDX | Purchase | Common Stock, par value $0.001 per share | 8.3k | $3.00 | $24.9k | | 06/09/2020 |
| 11/25/2019 | Onconova Therapeutics, Inc. | ONTX | Purchase | Common Stock | 150k | $0.20 | $30k | | 11/25/2019 |
| 11/25/2019 | Onconova Therapeutics, Inc. | ONTX | Purchase | Warrant (right to purchase) | 150k | $0.20 | $30k | | 11/25/2019 |
| 09/25/2019 | Onconova Therapeutics, Inc. | ONTX | Purchase | Common Stock | 7.3k | $1.60 | $11.6k | | 09/25/2019 |
| 09/25/2019 | Onconova Therapeutics, Inc. | ONTX | Other | Warrant (right to purchase) | 5k | $0.00 | $0 | | 09/25/2019 |
| 09/25/2019 | Onconova Therapeutics, Inc. | ONTX | Purchase | Warrant (right to purchase) | 5k | $0.11 | $533.5 | | 09/25/2019 |
| 09/25/2019 | Onconova Therapeutics, Inc. | ONTX | Other | Warrant (right to purchase) | 1.5k | $0.00 | $0 | | 09/25/2019 |
| 09/25/2019 | Onconova Therapeutics, Inc. | ONTX | Purchase | Warrant (right to purchase) | 1.5k | $0.11 | $157.1 | | 09/25/2019 |
| 07/26/2019 | Onconova Therapeutics, Inc. | ONTX | Grant | Stock Option (right to purchase) | 5.8k | $3.39 | $19.8k | | 07/26/2019 |
| 06/19/2019 | Celldex Therapeutics, Inc. | CLDX | Grant | | 4.5k | $2.78 | $12.5k | | 06/19/2019 |
| 08/24/2018 | Celldex Therapeutics, Inc. | CLDX | Purchase | Common Stock, par value $0.001 per share | 40k | $0.48 | $19.2k | | 08/24/2018 |
| 07/26/2018 | Onconova Therapeutics, Inc. | ONTX | Grant | Stock Option (right to purchase) | 87.5k | $0.46 | $40.2k | | 07/26/2018 |
| 06/13/2018 | Celldex Therapeutics, Inc. | CLDX | Grant | | 67k | $0.60 | $40.3k | | 06/13/2018 |
| 04/27/2018 | Onconova Therapeutics, Inc. | ONTX | Purchase | Common Stock | 58.9k | $0.00 | $0 | | 04/27/2018 |
| 04/27/2018 | Onconova Therapeutics, Inc. | ONTX | Purchase | Warrant (right to purchase) | 58.9k | $0.43 | $25k | | 04/27/2018 |
| 02/08/2018 | Onconova Therapeutics, Inc. | ONTX | Purchase | Warrant (right to purchase) | 50k | $1.01 | $50.5k | | 02/08/2018 |
| 02/08/2018 | Onconova Therapeutics, Inc. | ONTX | Purchase | Common Stock | 50k | $0.00 | $0 | | 02/08/2018 |
| 06/15/2017 | Celldex Therapeutics, Inc. | CLDX | Grant | Common Stock, par value $0.001 per share | 10k | $0.00 | $0 | | 06/15/2017 |
| 06/15/2017 | Celldex Therapeutics, Inc. | CLDX | Grant | | 15k | $2.32 | $34.8k | | 06/15/2017 |
| 06/12/2017 | Onconova Therapeutics, Inc. | ONTX | Grant | Stock Option (right to purchase) | 1.5k | $1.94 | $2.9k | | 06/12/2017 |
| 03/01/2017 | Celldex Therapeutics, Inc. | CLDX | Grant | | 8k | $3.56 | $28.5k | | 03/01/2017 |
| 08/01/2016 | Onconova Therapeutics, Inc. | ONTX | Exercise (in-the-money or at-the-money) | Common Stock | 24.4k | $4.10 | $100.1k | | 07/26/2016 |
| 08/01/2016 | Onconova Therapeutics, Inc. | ONTX | Exercise (in-the-money or at-the-money) | Warrants (right to buy) | 18.3k | $4.92 | $90.1k | | 07/26/2016 |
| 07/26/2016 | Onconova Therapeutics, Inc. | ONTX | Exercise (in-the-money or at-the-money) | Subscription Rights (right to buy) | 15 | $4.10 | $61.5 | | 07/26/2016 |